Molecular targets of doxazosin in human prostatic stromal cells. Read more about Molecular targets of doxazosin in human prostatic stromal cells.
Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Read more about Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
Molecular analysis of WFDC1/ps20 gene in prostate cancer. Read more about Molecular analysis of WFDC1/ps20 gene in prostate cancer.
Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Read more about Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR. Read more about Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR.
Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Read more about Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Read more about Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci.
Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line. Read more about Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line.
Quantitation of apoptotic activity following castration in human prostatic tissue in vivo. Read more about Quantitation of apoptotic activity following castration in human prostatic tissue in vivo.
Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis. Read more about Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.
